Menlo Park, California -- Medical device company Acclarent announced that it has raised $26 million in its series D round of institutional venture capital financing.
Acclarent is developing endoscopic, catheter-based, sinus surgery medical devices that it says are alternatives to conventional surgical approaches.
Investors in the round included Johnson & Johnson Development Corporation, New Enterprise Associates, Delphi Ventures, Versant Ventures and Meritech Capital Partners. The company said it will use the proceeds to "continue commercialization of its Balloon Sinuplasty technology." |